In Vivo Preclinical Testing Services

The contract seeks qualified contractors to conduct in vivo preclinical animal studies evaluating the anti-fertility efficacy, reproductive toxicity, pharmacodynamics, and general safety profiles of therapeutic candidates. These studies are critical for determining the potential impact of novel therapies on reproductive systems and overall organismal health prior to human trials, requiring strict adherence to standardized protocols and ethical animal care guidelines. The work must be performed by experienced preclinical research teams with demonstrated capabilities in reproductive toxicology and pharmacodynamic assessment across relevant animal models. This subcontract is issued under the National Institutes of Health, National Institute of Child Health and Human Development, part of the Department of Health and Human Services, and is classified under NAICS code 541620 for scientific research and development services. The opportunity was posted on April 28, 2026, with a firm deadline for responses on May 28, 2026, at 8:00 PM. While specific location details for performance or contact information are not provided, interested parties must be prepared to meet all federal regulatory requirements for animal research and deliver comprehensive, analyzable data packages. The solicitation does not specify set-aside status, indicating open competition for eligible entities.